Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ana-Carolina Caballero"'
Autor:
Gloria Iacoboni, Víctor Navarro, Pierre Sesques, Kai Rejeski, Mariana Bastos-Oreiro, Fabio Serpenti, Ana Africa Martin Lopez, Josu Iraola-Truchuelo, Javier Delgado, Ariadna Perez, Manuel Guerreiro, Ana Carolina Caballero, Nuria Martinez-Cibrian, Hugo Luzardo Henriquez, Jose Maria Sanchez Pina, Juan-Manuel Sancho, Hervé Ghesquieres, Alberto Mussetti, Lucia Lopez Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Francesc Bosch, Alejandro Martin Garcia-Sancho, Mi Kwon, Marion Subklewe, Andrea Kuhnl, Emmanuel Bachy, Pere Barba, Guillermo Villacampa, Pau Abrisqueta
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-10 (2024)
Abstract Chimeric antigen receptor (CAR) T-cell therapy fails to achieve durable responses in over 60% of relapsed/refractory (R/R) large B-cell lymphoma (LBCL) patients in the third or later line setting. After CAR-T failure, survival outcomes are h
Externí odkaz:
https://doaj.org/article/7a33c510abd6496482324ad69e68ca9f
Autor:
Gloria Iacoboni, Josu Iraola‐Truchuelo, Maeve O'Reilly, Víctor Navarro, Tobias Menne, Mi Kwon, Ana África Martín‐López, Sridhar Chaganti, Javier Delgado, Claire Roddie, Ariadna Pérez, Jane Norman, Manuel Guerreiro, Adam Gibb, Ana Carolina Caballero, Caroline Besley, Nuria Martínez‐Cibrián, Alberto Mussetti, Robin Sanderson, Hugo Luzardo, Sunil Iyengar, Jose Maria Sánchez, Ceri Jones, Juan‐Manuel Sancho, Pere Barba, Anne‐Louise Latif, Lucia López‐Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Alejandro Martin Garcia‐Sancho, Mariana Bastos, Pau Abrisqueta, Andrea Kuhnl
Publikováno v:
HemaSphere, Vol 8, Iss 5, Pp n/a-n/a (2024)
Abstract Over 60% of relapsed/refractory (R/R) large B‐cell lymphoma (LBCL) patients who receive chimeric antigen receptor (CAR) T cells will experience disease progression. There is no standard next line of therapy and information in this setting
Externí odkaz:
https://doaj.org/article/da69c64401f4489eb88ab02b2a46bb49
Autor:
Antonio Pérez-Martínez, Carlos Solano, Mi Kwon, Joaquín Martinez, Anna Sureda, Pedro Castro-Rebollo, Lucia López-Corral, Pere Barba-Suñol, Valentín Ortiz, Jaime Sanz-Caballer, Ana Carolina Caballero, Ángel Cedillo
Publikováno v:
BMJ Open, Vol 13, Iss 7 (2023)
Objectives To estimate the readiness of Spanish National Health Service (NHS) hospitals to provide chimeric antigen receptor T cell (CAR-T), and to identify and quantify the different resources needed to provide CAR-T considering three scenarios defi
Externí odkaz:
https://doaj.org/article/04ea0c0ba3424d709bb9eff4dd5b39d4
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Immunotherapy with T cells genetically modified with chimeric antigen receptors (CARs) has shown significant clinical efficacy in patients with relapsed/refractory B-cell lymphoma. Nevertheless, more than 50% of treated patients do not benefit from s
Externí odkaz:
https://doaj.org/article/3190287735184d8c90c4d93746d5229d
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
Autor:
Mi Kwon, Gloria Iacoboni, Juan Luis Reguera, Lucía López Corral, Rafael Hernani Morales, Valentín Ortiz-Maldonado, Manuel Guerreiro, Ana Carolina Caballero, María Luisa Guerra Domínguez, Jose Maria Sanchez Pina, Alberto Mussetti, Juan Manuel Sancho, Mariana Bastos-Oreiro, Eva Catala, Javier Delgado, Hugo Luzardo Henriquez, Jaime Sanz, María Calbacho, Rebeca Bailén, Cecilia Carpio, Jose Maria Ribera, Anna Sureda, Javier Briones, Juan Carlos Hernandez-Boluda, Nuria Martínez Cebrián, Jose Luis Diez Martin, Alejandro Martín, Pere Barba
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CD19-targeted chimeric antigen receptor (CAR) T cells approved for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). We performed a retrospective study to evaluate safety and
Externí odkaz:
https://doaj.org/article/7877186aef5347968a5ec57a48454215
Autor:
Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez‐Cibrian, Rebeca Bailén, Lucia Lopez Corral, Jose M. Sanchez, Manuel Guerreiro, Ana Carolina Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martin Garcia‐Sancho, Mi Kwon, Juan Luis Reguera‐Ortega, Pere Barba, GETH, GELTAMO Spanish Groups
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3214-3223 (2021)
Abstract Tisagenlecleucel (tisa‐cel) is a second‐generation autologous CD19‐targeted chimeric antigen receptor (CAR) T‐cell therapy approved for relapsed/refractory (R/R) large B‐cell lymphoma (LBCL). The approval was based on the results o
Externí odkaz:
https://doaj.org/article/c5750ec54d2047259016169d6fdbead9
Autor:
Laura Escribà-Garcia, Carmen Alvarez-Fernández, Ana Carolina Caballero, Robert Schaub, Jorge Sierra, Javier Briones
Publikováno v:
OncoImmunology, Vol 8, Iss 2 (2019)
Invariant natural killer T (iNKT) cells are a small population of T lymphocytes that expresses an invariant T cell receptor with a unique specificity for glycolipid antigens. Their activation using the glycolipid α-galactosylceramide (α-GalCer) tri
Externí odkaz:
https://doaj.org/article/9444ccb3151040a3992616c6866f1890
Autor:
Sara Redondo, Irene García‐Cadenas, Antonio Vila, Albert Esquirol, J. M. Portos, Silvana Novelli, Silvana Saavedra, Carol Moreno, Ana Garrido, Miguel Arguello‐Tomas, Guadalupe Oñate, Jordi López‐Pardo, Ana‐Carolina Caballero, Sara Miqueleiz, Javier Briones, Jorge Sierra, Gemma Sancho, Rodrigo Martino
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8abe06bfb13bdc70413cf4c65e256f2
https://doi.org/10.1111/ejh.13978
https://doi.org/10.1111/ejh.13978
Autor:
Irene García-Cadenas, Sara Redondo, Albert Esquirol, J.M. Portos, Silvana Novelli, Silvana Saavedra, Carol Moreno, Ana Garrido, Guadalupe Oñate, Jordi López, Ana-Carolina Caballero, Sara Miqueleiz, Miguel Arguello-Tomas, Javier Briones, Jorge Sierra, Rodrigo Martino
Publikováno v:
Transplantation and Cellular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d152ab3d6d7505108c8151f772a5cb9
https://doi.org/10.1016/j.jtct.2023.04.008
https://doi.org/10.1016/j.jtct.2023.04.008
Autor:
Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro, Blanca Rius-Sansalvador, Carmen Albo, Rebeca Bailen, Pere Barba, Ana Benzaquén, Javier Briones, Ana Carolina Caballero, António Campos, Ignacio Español, Christelle Ferra, Sebastián Garzón López, Pedro Antonio González Sierra, Luisa Maria Guerra, Rafael Hernani, Gloria Iacoboni, Ana Jiménez-Ubieto, Mi Kwon, Lucía López Corral, Oriana López-Godino, Maria Carmen Martinez Munoz, Nuria Martínez-Cibrián, Juan Montoro Gómez, Laura Pérez-Ortega, Guillermo Ortí, Valentín Ortiz-Maldonado, Maria-Jesús Pascual, María Perera, Antonio Perez, Juan Luis Reguera, Jose M. Sanchez, Jaime Sanz, Anna Torrent, Lucrecia Yáñez, Rosario Varela, Izaksun Ceberio Echechipia, Dolores Caballero, Anna Sureda
Publikováno v:
Bone Marrow Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f2a71db46333e239455395fe227f5e6
https://doi.org/10.1038/s41409-023-01949-x
https://doi.org/10.1038/s41409-023-01949-x